A consensus on the diagnosis and treatment of acromegaly complications
Casanueva, F. F.
Bronstein, M. D.
Lamberts, S. W.
Strasburger, C. J.
Wass, J. A. H.
MetadataShow full item record
CitationMelmed, S., F. F. Casanueva, A. Klibanski, M. D. Bronstein, P. Chanson, S. W. Lamberts, C. J. Strasburger, J. A. H. Wass, and A. Giustina. 2012. “A consensus on the diagnosis and treatment of acromegaly complications.” Pituitary 16 (1): 294-302. doi:10.1007/s11102-012-0420-x. http://dx.doi.org/10.1007/s11102-012-0420-x.
AbstractIn March 2011, the Acromegaly Consensus Group met to revise and update the guidelines on the diagnosis and treatment of acromegaly complications. The meeting was sponsored by the Pituitary Society and the European Neuroendocrinology Association and included experts skilled in the management of acromegaly. Complications considered included cardiovascular, endocrine and metabolic, sleep apnea, bone diseases, and mortality. Outcomes in selected, related clinical conditions were also considered, and included pregnancy, familial acromegaly and invasive macroadenomas. The need for a new disease staging model was considered, and design of such a tool was proposed.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:11855918
- HMS Scholarly Articles 
Contact administrator regarding this item (to report mistakes or request changes)